NEXTRAST, INC
Burlingame, CA · Medtech · Private
Tantalum nanoparticle blood pool contrast agent for CT vascular imaging
- Grants
- $7.2M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Novel Bowel Contrast Agent for Dual Energy CT | $349,825 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Bowel Contrast Agent for Dual Energy CT | $597,798 | |
| Federal grant | Department of Health and Human Services · Phase II · Augmenting Dual Energy CT for Novel Contrast Agents | $499,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Bowel Contrast Agent for Dual Energy CT | $594,627 | |
| Federal grant | Department of Health and Human Services · Phase II · Augmenting Dual Energy CT for Novel Contrast Agents | $489,046 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Bowel Contrast Agent for Dual Energy CT | $594,198 | |
| Federal grant | Department of Health and Human Services · Phase II · Augmenting Dual Energy CT for Novel Contrast Agents | $489,046 | |
| Federal grant | Department of Health and Human Services · Phase II · Vascular CT contrast agent development | $249,980 | |
| Federal grant | Department of Health and Human Services · Phase II · Vascular CT contrast agent development | $1,665,443 | |
| Federal grant | Department of Health and Human Services · Phase II · Vascular CT contrast agent development | $843,622 | |
| Federal grant | Department of Health and Human Services · Phase II · Vascular CT contrast agent development | $821,821 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 684 | ECATE LLC | — | — |
| 685 | THERMOBIONICS L.L.C. | — | — |
| 686 | ACCURE HEALTH INC | — | — |
| 687 | NEXTRAST, INC | — | — |
| 688 | Atomnaut Inc. | — | — |
| 689 | Cannabix Technologies Inc. | — | $440K |
| 690 | CURRENT SURGICAL INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.